Med SciforuMed Sciforu

Interface in English. Medical references retain their original language; bilingual names and selected translations are provided.

西药 · 美国药品标签原文

SENNA-S

SENNA AND DOCUSATE SODIUM TABLETS, 8.6 MG AND 50 MG

SENNA-S · HealthLife of USA LLC。此记录对应特定产品,标签收录不代表所有用途获批。

说明与适用边界

此页按所列地区、版本归档。标签内容可能更新,具体产品请核对原始来源;本站关联表示阅读线索,不表示药品与器械可兼容或可替换。

spl product data elements

SENNA-S Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg CROSCARMELLOSE SODIUM SILICON DIOXIDE CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE D&C YELLOW NO. 10 FD&C YELLOW NO. 6 HYPROMELLOSES CELLULOSE, MICROCRYSTALLINE MAGNESIUM STEARATE MALTODEXTRIN POLYETHYLENE GLYCOL 1000 STEARIC ACID TITANIUM DIOXIDE SENNOSIDES SENNOSIDES DOCUSATE SODIUM DOCUSATE S35

spl unclassified section

Drug Facts

活性成分 / Active ingredient

Active ingredients Purpose (in each tablet) Purpose Docusate sodium 50 mg.......................................Stool softner Sennosides 8.6 mg................................................Laxative

用途 / Purpose

Active ingredients Purpose (in each tablet) Purpose Docusate sodium 50 mg.......................................Stool softner Sennosides 8.6 mg................................................Laxative

适应证 / Indications and usage

Uses relieves occasional constipation (irregularity) generally produces bowel movement in 6-12 hours

警告 / Warnings

Warnings Do not use if you are now taking mineral oil, unless directed by a doctor laxative products for longer than 1 week unless directed by a doctor Ask a doctor before use if you have stomach pain nausea vomiting noticed a sudden change in bowel habits that lasts over 2 weeks Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition. If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

咨询医生 / Ask a doctor

Ask a doctor before use if you have stomach pain nausea vomiting noticed a sudden change in bowel habits that lasts over 2 weeks

停用事项 / Stop use

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

孕哺期 / Pregnancy or breastfeeding

If pregnant or breast-feeding , ask a health professional before use.

儿童安全 / Keep out of reach of children

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

用法用量原文 / Dosage and administration

Directions take preferably at bedtime or as directed by a doctor adults and children 12 years of age or older - starting dosage: 2 tablets once a day, maximum dosage: 4 tablets twice a day children 6 to under 12 years - starting dosage: 1 tablet once a day, maximum dosage: 2 tablets twice a day children 2 to under 6 years - starting dosage: 1/2 tablet once a day, maximum dosage: 1 tablet twice a day children under 2 years - starting dosage: ask a doctor, maximum dosage: ask a doctor

储存 / Storage and handling

Other information each tablet contains: calcium 21 mg each tablet contains: sodium 3 mg VERY LOW SODIUM store at 25ºC (77ºF); excursions permitted between 15°-30°C (59°-86°F) read all product information before using TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

辅料 / Inactive ingredients

Inactive ingredients croscarmellose sodium, colloidal silicon dioxide, dicalcium phosphate, D&C Yellow # 10, FD&C Yellow # 6, hypromellose, microcrystalline cellulose, magnesium stearate, maltodextrin, polyethylene glycol, stearic acid, titanium dioxide

questions

Questions or comments? Call toll free 1-844-832-1138 Monday through Friday 9AM – 5PM EST or www.healthlifeofusa.com

package label principal display panel

PRINCIPAL DISPLAY PANEL Compare to the Active Ingredients in Senokot-S® *This product is not manufactured or distributed by Purdue Products L.P., owner of the registered trademark Senokot-S®. Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg Principal Display Panel

来源、版本与许可

资料类型
美国药品标签原文
版本
9 / 20231021
获取时间
2026-10-08
许可
openFDA public data; retain original label attribution. See 查看来源 and dataset source notices. Public access does not imply approval or unrestricted rights to every submitted label.
核对原始来源